Clinicians & Researchers

You are here

PETAL Network Bibliography

Export 31 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR et al..  2020.  Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial . JAMA.
Berger JS, Neal MD, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Althouse AD, Lawler PR, McVerry BJ, Kim KS et al..  2023.  Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.. JAMA Netw Open. 6(5):e2314428.
Berger JS, Neal MD, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Althouse AD, Lawler PR, McVerry BJ, Kim KS et al..  2023.  Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.. JAMA Netw Open. 6(5):e2314428.
Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B et al..  2022.  Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.. JAMA. 327(3):227-236.
Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B et al..  2022.  Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.. JAMA. 327(3):227-236.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
T
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.